About this item:

821 Views | 1,134 Downloads

Author Notes:

Corresponding author: Banu Aygun, MD Steven and Alexandra Cohen Children's Medical Center of NY Division of Pediatric Hematology/Oncology and Stem Cell Transplantation 269-01 76th Avenue, Suite 255 New Hyde Park, NY 11040 Tel. (718) 470-3095/ Fax (718) 343-2961 baygun@nshs.edu.

BA, NAM, WHS, ARC,OA, ZRR, JLK, STM, PS, RI, PAL, REW and the SWiTCH Trial investigators performed the research.

REW, NAM, WHS, BA designed the research study.

BA, NAM, KK, AL, REW analysed the data.

BA, REW, NAM, KK, AL, WHS, ARC,OA, ZRR, JLK, STM, PS, RI, PAL wrote the paper.

We thank the SWITCH personnel at the participating clinical centres listed in the Appendix, as well as the children and their families for their commitment.

The authors have no competing interests.

Subjects:

Research Funding:

The SWiTCH Clinical Trial was supported by the National Heart, Lung and Blood Institute of the National Institutes of Health (grants U01-HL078787 to REW and U01-HL078987 to Ronald W. Helms at Rho) and Novartis Inc. for donation of deferasirox for study participants on the Standard Treatment Arm.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Hematology
  • sickle cell
  • iron overload
  • phlebotomy
  • liver iron
  • HYDROXYUREA SWITCH
  • SECONDARY STROKE
  • PREVENTION
  • DISEASE
  • EFFICACY

Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overload

Show all authors Show less authors

Tools:

Journal Title:

British Journal of Haematology

Volume:

Volume 169, Number 2

Publisher:

, Pages 262-266

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Serial phlebotomy was performed on sixty children with sickle cell anaemia, stroke and transfusional iron overload randomized to hydroxycarbamide in the Stroke With Transfusions Changing to Hydroxyurea trial. There were 927 phlebotomy procedures with only 33 adverse events, all of which were grade 2. Among 23 children completing 30 months of study treatment, the net iron balance was favourable (-8·7 mg Fe/kg) with significant decrease in ferritin, although liver iron concentration remained unchanged. Therapeutic phlebotomy was safe and well-tolerated, with net iron removal in most children who completed 30 months of protocol-directed treatment.

Copyright information:

© 2015 John Wiley & Sons Ltd.

Export to EndNote